There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:A61K31/517
Jump to navigation
Jump to search
Subcategories
This category has the following 2 subcategories, out of 2 total.
Pages in category "A61K31/517"
The following 18 pages are in this category, out of 18 total.
1
- 18271926. COMBINATION THERAPEUTICS FOR TREATMENT OF PROLIFERATIVE DISORDERS simplified abstract (GEORGIA TECH RESEARCH CORPORATION)
- 18546317. COMPOSITIONS AND METHODS FOR INHIBITING KRAS simplified abstract (LAWRENCE LIVERMORE NATIONAL SECURITY, LLC)
- 18547871. DEVELOPMENT OF PRMT-TARGETING THERAPY TO ENHANCE EGFR-TARGETING DRUG EFFICACY IN NSCLC simplified abstract (The Regents of the University of California)
- 18580703. BIOMIMETIC, REACTIVE OXYGEN SPECIES-DETONABLE NANOCLUSTERS FOR ANTIRESTENOTIC THERAPY simplified abstract (WISCONSIN ALUMNI RESEARCH FOUNDATION)
- 18663549. METHODS AND COMPOSITIONS COMPRISING A KRASG12C INHIBITOR AND A VEGF INHIBITOR FOR TREATING SOLID TUMORS simplified abstract (Genentech, Inc.)
- 18706482. EXTRACELLULAR RNA SIGNATURES OF MUTANT KRAS(G12C) CANCERS (The Regents of the University of California)
- 18737814. COATED DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME (Applied Materials, Inc.)
- 18942238. METHODS FOR THE TREATMENT OF NLRP3 RELATED DISORDERS (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
B
T
- The regents of the university of california (20240299356). DEVELOPMENT OF PRMT-TARGETING THERAPY TO ENHANCE EGFR-TARGETING DRUG EFFICACY IN NSCLC simplified abstract
- The regents of the university of california (20250064808). METHODS FOR THE TREATMENT OF NLRP3 RELATED DISORDERS
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA patent applications on February 27th, 2025
- The Regents of the University of California patent applications on September 12th, 2024
